In its confirmatory trial, Leqembi was shown to reduce clinical decline in mild to moderate Alzheimers by 27%, while donanemab reduced decline in early symptomatic Alzheimers by up to 36%
Functional Motifs and Sequence Patterns When researchers talk about motifs, theyre really talking about recurring patternslittle clusters of amino acids that tend to drive certain behaviors
I would highly recommend it
Lancet 402(10400):472483
Staying on top of your health can feel overwhelming at times
10.1016/S0953-6205(03)00104-3 Bohan TP, Helton E, McDonald I, Konig S, Gazitt S, Sugimoto T, Scheffner D, Cusmano L, Li S, Koch G: Effect of L-carnitine treatment for valproate-induced hepatotoxicity